News
Circadin is Approved in the EU for Treatment of Primary Insomnia in Patients Aged 55 or Over for up to 3 Months
July 5, 2010 3:38 pm | by Bio-Medicine.Org | CommentsTEL AVIV, Israel , July 5, 2010 /- Neurim Pharmaceuticals ( http://www.Neurim.com ) confirmed today that the European Commission (EC) has approved a change in treatment duration with Circadin from 3 to 13 weeks (3 months). Circadin is indicated for the treatment of primary insomnia in...
New tool to rule out coronary heart disease in primary care
July 5, 2010 3:36 pm | by EurekAlert | Comments(Canadian Medical Association Journal) A simple new rule can help primary care physicians rule out coronary heart disease in patients with chest pain, states a study published in CMAJ.
Depression symptoms show little change during the development and progression of Alzheimer's disease
July 5, 2010 3:36 pm | by EurekAlert | Comments(Rush University Medical Center) Researchers at Rush University Medical Center found that depressive symptoms show little change during the development and progression of Alzheimer's disease. The study suggests that depression is truly a risk factor for Alzheimer's disease and not...
Heart patients with anxiety disorder experience more cardiovascular events, deaths
July 5, 2010 3:36 pm | by EurekAlert | Comments(JAMA and Archives Journals) Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.
Digital embryo gains wings
July 5, 2010 12:38 am | by EurekAlert | Comments(European Molecular Biology Laboratory) Scientists at the European Molecular Biology Laboratory have captured fruit fly development on film, creating the Fly Digital Embryo. In work published today in Nature Methods, they were also the first to clearly record how a zebrafish's eyes...
FDA Approves Strativa Pharmaceuticals' Zuplenz® (ondansetron) Oral Soluble Film
July 2, 2010 8:36 pm | by Bio-Medicine.Org | CommentsWOODCLIFF LAKE, N.J. , July 2 /- Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) has approved Zuplenz® (ondansetron) oral soluble film for the prevention of postoperative, highly and moderately emetogenic cancer chemotherapy-induced, and...
Cepheid Xpert MRSA-SA Blood Culture Assay for Use with the GeneXpert Dx System: Class I Recall
July 2, 2010 8:31 pm | by U.S. Food & Drug Administration | CommentsThe firm received increasing numbers of complaints for false negative MRSA results. False negative could result in incorrect treatment or delay of care for patients with MRSA infection.
Wallabies and bats harbor 'fossil' genes from the most deadly family of human viruses
July 2, 2010 11:38 am | by EurekAlert | Comments(University at Buffalo) Modern marsupials may be popular animals at the zoo and in children's books, but new findings by University at Buffalo biologists reveal that they harbor a "fossil" copy of a gene that codes for filoviruses, which cause Ebola and Marburg hemorrhagic fevers...
Yale Researchers win $3.5M for Hepatitis C study
July 2, 2010 11:37 am | by Mass High Tech: The Journal of New England Technology | CommentsYale University researchers have received a $3.5 million grant from the National Institutes of Health to fund a study of hepatitis C virus. a deadly pathogen that attacks the liver and afflicts about 170 million people worldwide.
MiMedx Group, Inc. Announces Release Date for Second Quarter Results
July 2, 2010 11:36 am | by Bio-Medicine.Org | CommentsMARIETTA, Ga. , July 2 /- MiMedx Group, Inc. (OTC Bulletin Board: MDXG), an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that its results for the second quarter, ended June 30, 2010 , will be released before the opening of...
Watson Completes Acquisition of CRINONE® and PROCHIEVE® Product Line and Shares of Columbia Laboratories
July 2, 2010 11:36 am | by Bio-Medicine.Org | CommentsMORRISTOWN, N.J. , July 2 /- Watson Pharmaceuticals, Inc. (NYSE: WPI ) today completed the acquisition of the U.S. rights to Columbia Laboratories' CRINONE® and PROCHIEVE® progesterone gel product line and 11,200,000 shares of Columbia common stock. "We are pleased to add...
LIFEPAK 20 and LIFEPAK 20e External Defibrillator/Monitors by Physio-Control Inc.: Class I Recall Due To Power Supply Failure(2)
July 2, 2010 11:31 am | by U.S. Food & Drug Administration | CommentsA power supply assembly failure can result in the inability to deliver defibrillation therapy.
LIFEPAK 20 and LIFEPAK 20e External Defibrillator/Monitors by Physio-Control Inc.: Class I Recall Due To Power Supply Failure
July 2, 2010 11:30 am | CommentsA power supply assembly failure can result in the inability to deliver defibrillation therapy.
Micrus replacing CKE on S & P SmallCap 600
July 2, 2010 8:45 am | by The Associated Press | CommentsStandard & Poor's said Friday that medical device maker Micrus Endovascular Corp. will replace CKE Restaurants Inc. in the S&P SmallCap 600 index after the close of trading on July 7.CKE Restaurants is being acquired by affiliates of Apollo Management in a deal expected to close on or about...
EEOC sues company over harassment in Wis. store
July 2, 2010 7:45 am | by The Associated Press | CommentsA federal agency is accusing a Kentucky company of permitting a sexually hostile work environment in one of its Wisconsin pharmacies.The U.S. Equal Employment Opportunity Commission said Thursday it has filed a federal lawsuit. The suit names Covington, Ky.-based Omnicare Inc., which does...
